Press Releases

Providence selects Darryl A. Elmouchi, M.D., MBA, as its new chief operating officer, effective Jan. 2.

Real-world data from Providence, Illumina and Microsoft Research finds cancer patients with early genomic testing received better precision treatment, underlines urgency to become standard practice

Health Connect Partners (HCP), Providence's Medicare Shared Savings Program (MSSP) Accountable Care Organization (ACO), generated more than $137 million in savings to CMS in 2023.

New study evaluates a type of CAR T-cell therapy called liso-cel. Researchers will collect data from multiple groups in a study that may give patients hope for long-term remission and quality of life.

Explore promising clinical trials at Providence Cancer Institute that are investigating immunotherapy for early-stage TNBC and high-risk, HR-positive breast cancer.

Providence and Compassus have announced an agreement to form a joint venture partnership for home health, hospice, community-based palliative care, and private duty caregiving services.

Baylor Scott & White Health, Memorial Hermann Health System, Novant Health and Providence have announced the formation of Longitude Health.

Year-long study, published in Health Affairs Scholar, prompts need for multi-level intervention to increase adoption rates, combat cancer inequities

A study released today indicates that burden of quality measures may be counterproductive in patient care, suggests possible need for intervention

Data published in the New England Journal of Medicine Catalyst reported that MedPearl, a Providence-developed platform, improves primary care clinician productivity, decreases time waste.

Providence announced results for the three months ended June 30, 2024, which showed continued improvement in operating performance.

A new medication may help people with KRAS G12C-mutant non-small cell lung cancer. Read about the study and a trial evaluating an immunotherapy for treating head and neck squamous cell carcinoma.